http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
서일국 ( Il Kook Seo,),최인선 ( In Seon S. Choi ),김상훈 ( Sang Hoon Kim ),한의령 ( Eui Ryoung Han ) 대한천식알레르기학회 2011 천식 및 알레르기 Vol.31 No.1
Background: Anti-asthma treatments correct impaired dyspneaperception. Objective: To investigate whether dyspnea perception in asthmatics vary whenever they are hospitalized. Method: We retrospectively analyzed the medical records of 64 patients (32 men and 32 women) with acute asthma who were hospitalized at least twice and assessed using the Borg scale-based dyspnea perception score while breathing through an inspiratory muscle trainer at each admission. Poor perceiver was defined as a Borg score of ≤5 at the highest resistive load (HR) and HR-induced ΔBorg score of ≤3. Result: Between the first and econd admissions, the relationship of forced expiratory volume in 1 s (r=0.773, P <0.001) and the concordance of severity of asthma attack (κ=0.503, P<0.001) were significant, but the relationship of HR-induced ΔBorg score and the concordance of poor perceivers were not. During the first admission, as lung function increased gradually, the HR-induced ΔBorg score became higher in poor perceivers (1.83±0.39→3.42±0.57→4.00±0.67, P=0.048). Conclusion: Although asthmatic patients who suffered from a severe asthma attack tended to have a severe attack again at the following admission, dyspnea perception differs among the admissions. Impaired dyspnea perception during acute asthmatic attack would be correctable with anti-asthma treatments. (Korean J Asthma Allergy Clin Immunol 2011;31:20-26)
최홍상,정명호,서일국,이민구,고점석,박근호,심두선,윤남식,김계훈,박형욱,홍영준,김주한,안영근,조정관,박종춘,강정채 대한심장학회 2011 Korean Circulation Journal Vol.41 No.7
Stent thrombosis is a fatal complication in patients who have undergone percutaneous coronary intervention, and discontinuation of anti-platelet agent is a major risk factor of stent thrombosis. We report a rare case of very late stent thrombosis (VLST) following discontinuation of anti-platelet agents in a patient who experienced acute myocardial infarction and essential thrombocytosis. She had undergone implantation of a drug eluting stent (DES) and a bare metal stent (BMS) two and half years prior to her presentation. VLST developed in DES, not in BMS, following interruption of anti-platelet therapy.
천식환자에서 ciclesonide의 치아와 하악골 골 밀도에 대한 영향 평가를 위한 단일군 연구
최인선,정조윤,김하연,김성은,김태옥,류성윤,김민지,서일국,이정현,강현욱,김창성,조경훈,김민철,한의령,박진균 대한내과학회 2011 대한내과학회 추계학술발표논문집 Vol.2011 No.1
배경: 흡입용 스테로이드 장기 사용 때 하악골 골 밀도(BMD) 저하와 치아 결손이 동반된다. 그러나 새로운 흡입용 스테로이드인ciclesonide는 국소 및 전신 부작용이 적다고 알려져 있어서 ciclesonide가 골다공증이 생기기 쉬운 폐경 후 여성에서도 BMD가 자연적 저하와 이가없는 변화를 초래하는지를 보기 위해 연구하였다. 연구방법: 45세 이상 폐경 후 여자 천식환자 53명에서 cicleosonide를 1년간 사용기 전후하악골과 요추, 대퇴경부의 BMD, 치아 문제 등의 변화를 검토하였다. 연구결과: Ciclesonide 사용 전에 비해 후에 대퇴경부 BMD는 의한차이가 없었으나 요추(0.934±0.019 vs 0.912±0.018 g/cm2, p=0.001)와 하악골(0.814±0.058 vs 0.697±0.059 g/cm2, p=0.043)의 BM는 유의하게 저하되었다. BMD의 저하 정도는 요추 0.0223±0.0066 g/cm2과 하악골 0.1171±0.0564 g/cm2로서 정상 여성의 폐경 후 연간 저하치0.0125g/cm2에 비해 높은 경향이었으나 통계적으로 유의한 차이는 아니었다. 결론: Cicleosonide 사용 후 사용 전에 비해 요추와 하악골 BM가유의하게 저하되었으나 정상 여성의 자연적 저하 정도에 비해 유의한 차이는 아니어서 ciclesonide가 치아와 하악골 BMD에 영향이 은 비교적 안전한 약물이라고 생각한다.
Personal Factors Affecting Therapeutic Responses to BCG Vaccination in Asthmatics
최인선,한의령,김연주,윤주영,김성수,서일국,장연진,박춘식 대한천식알레르기학회 2011 Allergy, Asthma & Immunology Research Vol.3 No.3
Purpose: Bacille Calmette-Guérin (BCG) vaccination has been reported to be an effective treatment for asthma in several animal models. This study investigated whether the response to BCG treatment in asthma depends on subject clinical characteristics. Methods: Stable asthma patients were vaccinated with BCG. One month later, alterations in pulmonary function after vaccination and their relationships with subject clinical characteristics were determined. Results: Of 149 patients with asthma, 54 (36.2%) showed a good or fair response to BCG. The ΔFEV1 after vaccination was significantly related to age (r=-0.348, P<0.001), peripheral blood eosinophil counts (r=0.315, P<0.001) and baseline FEV1, expressed as % personal best value (r=-0.474, P<0.001), but not to FEV1 % predicted value (r=-0.066, P>0.05). A good/fair response was highly prevalent in atopic females compared with atopic males, especially among those aged ≤50 years (90.9% vs. 40.0%, P=0.024). Age (P<0.001, odds ratios (OR)=0.92, confidence interval (CI)=0.88-0.96) and atopy (P<0.01, OR=4.95, CI=1.70-14.44) were significant predictors for a good/fair response in females. However, blood eosinophil counts (P<0.05, OR=1.18, CI=1.01-1.39) and FEV1 % best (P<0.001, OR=0.86, CI=0.79-0.94), but not age or atopy, were significant predictors in males. Approximately three-quarters of the males were smokers. Conclusions: The therapeutic effect of BCG in asthma may differ according to patient clinical characteristics. The greatest benefit occurred in young atopic females. Asthma activity indices, such as eosinophilia and FEV1 % best, were more predictive of a good/fair response in males; this may have been related to cigarette smoking.